|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0009429,
umls-concept:C0013216,
umls-concept:C0023884,
umls-concept:C0026377,
umls-concept:C0031001,
umls-concept:C0032790,
umls-concept:C0045093,
umls-concept:C0205420,
umls-concept:C0445204,
umls-concept:C0450363,
umls-concept:C0543467,
umls-concept:C0556895,
umls-concept:C0851346
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2009-7-13
|
|
pubmed:abstractText |
To evaluate both the feasibility and efficacy of our combined therapy, which consisted of preoperative chemoradiation, surgery, and postoperative liver perfusion chemotherapy (LPC) for patients with T3 (extended beyond the pancreatic confines) cancer of the pancreas.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1528-1140
|
|
pubmed:author |
pubmed-author:EguchiHidetoshiH,
pubmed-author:GotohKunihitoK,
pubmed-author:IshikawaOsamuO,
pubmed-author:NakaizumiAkihikoA,
pubmed-author:NishiyamaKinjiK,
pubmed-author:OhigashiHiroakiH,
pubmed-author:TakahashiHidenoriH,
pubmed-author:TomitaYoshihikoY,
pubmed-author:UeharaHiroyukiH,
pubmed-author:YamadaTerumasaT,
pubmed-author:YanoMasahikoM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
250
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
88-95
|
|
pubmed:meshHeading |
pubmed-meshheading:19561477-Adenocarcinoma,
pubmed-meshheading:19561477-Adult,
pubmed-meshheading:19561477-Aged,
pubmed-meshheading:19561477-Aged, 80 and over,
pubmed-meshheading:19561477-Antimetabolites, Antineoplastic,
pubmed-meshheading:19561477-Chemotherapy, Adjuvant,
pubmed-meshheading:19561477-Combined Modality Therapy,
pubmed-meshheading:19561477-Deoxycytidine,
pubmed-meshheading:19561477-Feasibility Studies,
pubmed-meshheading:19561477-Female,
pubmed-meshheading:19561477-Humans,
pubmed-meshheading:19561477-Infusion Pumps, Implantable,
pubmed-meshheading:19561477-Liver Neoplasms,
pubmed-meshheading:19561477-Male,
pubmed-meshheading:19561477-Middle Aged,
pubmed-meshheading:19561477-Neoplasm Staging,
pubmed-meshheading:19561477-Pancreatectomy,
pubmed-meshheading:19561477-Pancreatic Neoplasms,
pubmed-meshheading:19561477-Perfusion,
pubmed-meshheading:19561477-Radiotherapy, Adjuvant,
pubmed-meshheading:19561477-Radiotherapy, Conformal,
pubmed-meshheading:19561477-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer.
|
|
pubmed:affiliation |
Departments of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashi-nari-ku, Osaka 537-8511, Japan. oohigasi-hi@mc.pref.osaka.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
